Healthcare provider profile · identity verified

Rick D Gillis, MD

Internal Medicine · MILWAUKEE, WI · NPI 1962453746

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	841	220
Amlodipine Besylate	Amlodipine Besylate	535	130
Losartan Potassium	Losartan Potassium	418	112
Lisinopril	Lisinopril	378	98
Tamsulosin Hcl	Tamsulosin Hcl	301	79
Levothyroxine Sodium	Levothyroxine Sodium	295	70
Omeprazole	Omeprazole	272	78
Pantoprazole Sodium	Pantoprazole Sodium	271	71
Gabapentin	Gabapentin	240	61
Simvastatin	Simvastatin	229	64
Metoprolol Succinate	Metoprolol Succinate	217	50
Rosuvastatin Calcium	Rosuvastatin Calcium	204	63
Eliquis	Apixaban	179	39
Allopurinol	Allopurinol	177	50
Furosemide	Furosemide	162	46
Albuterol Sulfate Hfa	Albuterol Sulfate	161	51
Hydrochlorothiazide	Hydrochlorothiazide	138	40
Metformin Hcl Er	Metformin Hcl	132	35
Jardiance	Empagliflozin	130	26
Metformin Hcl	Metformin Hcl	125	39
Pravastatin Sodium	Pravastatin Sodium	111	29
Escitalopram Oxalate	Escitalopram Oxalate	108	30
Warfarin Sodium	Warfarin Sodium	108	23
Carvedilol	Carvedilol	101	26
Fluticasone Propionate	Fluticasone Propionate	95	45
Spironolactone	Spironolactone	92	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	86	22
Metoprolol Tartrate	Metoprolol Tartrate	86	25
Potassium Chloride	Potassium Chloride	81	25
Sertraline Hcl	Sertraline Hcl	78	18
Clopidogrel	Clopidogrel Bisulfate	77	25
Tramadol Hcl	Tramadol Hcl	76	16
Zolpidem Tartrate	Zolpidem Tartrate	76	18
Ozempic	Semaglutide	74	15
Alprazolam	Alprazolam	71	15
Valsartan	Valsartan	71	17
Trazodone Hcl	Trazodone Hcl	70	23
Ezetimibe	Ezetimibe	66	17
Lorazepam	Lorazepam	66	suppressed
Donepezil Hcl	Donepezil Hcl	65	16
Oxycodone Hcl	Oxycodone Hcl	62	12
Glimepiride	Glimepiride	60	15
Tizanidine Hcl	Tizanidine Hcl	59	18
Pregabalin	Pregabalin	58	suppressed
Trulicity	Dulaglutide	56	12
Finasteride	Finasteride	55	16
Duloxetine Hcl	Duloxetine Hcl	53	18
Clonazepam	Clonazepam	52	suppressed
Famotidine	Famotidine	50	13
Mirtazapine	Mirtazapine	50	13
Mounjaro	Tirzepatide	50	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	suppressed
Meloxicam	Meloxicam	48	31
Bumetanide	Bumetanide	47	suppressed
Alendronate Sodium	Alendronate Sodium	46	13
Atenolol	Atenolol	45	14
Celecoxib	Celecoxib	43	suppressed
Montelukast Sodium	Montelukast Sodium	43	15
Chlorthalidone	Chlorthalidone	41	14
Citalopram Hbr	Citalopram Hydrobromide	41	11
Buspirone Hcl	Buspirone Hcl	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Azithromycin	Azithromycin	37	37
Synthroid	Levothyroxine Sodium	36	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	36	suppressed
Glipizide	Glipizide	35	suppressed
Prednisone	Prednisone	34	23
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Xarelto	Rivaroxaban	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Irbesartan	Irbesartan	32	suppressed
Olanzapine	Olanzapine	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	11
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Spiriva Handihaler	Tiotropium Bromide	25	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Topiramate	Topiramate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Diazepam	Diazepam	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Folic Acid	Folic Acid	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Testosterone	Testosterone	18	suppressed
Baclofen	Baclofen	17	suppressed
Dapagliflozin	Dapagliflozin Propanediol	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	12
Klor-Con M20	Potassium Chloride	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	15	suppressed
Amoxicillin	Amoxicillin	14	11
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Linzess	Linaclotide	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Colchicine	Colchicine	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Brilinta	Ticagrelor	12	suppressed
Estradiol	Estradiol	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Ramipril	Ramipril	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Temazepam	Temazepam	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error